MILabs B.V.
RELATED CONTENT
March 27, 2020 — Based on recent scientific research, diagnostic X-ray computed tomography (CT) is able to detect COVID ...
March 27, 2020 
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia, MILabs introduced the new VECTor6 positron emission tomography (PET) system loaded with innovative features. New features incorporated in its 4x4D omni-tomography design include PET, single photon emission computed tomography (SPECT), optical and X-ray computed tomography (CT) imaging modalities.
June 28, 2018 The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission Computed Tomography (VECTor5) system to support its translational oncology mission, entrusted by the Italian Ministry of Health and the Organization of the European Cancer Institutes. Due to its high-resolution imaging capabilities, MILabs’ preclinical VECTor can enable a quick translation of molecular research from the bench to the clinic at the IOV.
May 21, 2018 
The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the Year Award at the 2015 World Molecular Imaging Congress (WMIC) to Frederik Beekman, CEO/CSO, MILabs for his work developing G-SPECT.
September 23, 2015 
June 16, 2009 – MILabs introduced at the Annual SNM meeting its novel U-SPECT/CT system, a Micro-SPECT system that is fully integrated with the MILabs high-throughput, low dose U-CT. The company also announced it has already contracted to install two U-SPECT/CT systems.
June 16, 2009